Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Running, not enrolling

Conditions studied: Dermatitis Atopic

In brief

Primary Objectives: * To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable. * To evaluate the time-course of AD and selected atopic comorbidities. Secondary Objectives: * To characterize disease burden and unmet need. * To describe real-world treatment patterns (eg, dosing regimens, treatment duration, and reasons for discontinuation and/or switching). * To document the real-world effectiveness and safety of treatments.

Key facts

Study ID

NCT03687359

Run by

Sanofi

People needed

1860

Starts

2019-08-15

Expected to finish

2035-07-23

Last updated by the study team

2025-08-15

Who can join

Age: any, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with moderate to severe AD, according to the Investigator's assessment;
• Currently receiving systemic treatment (including phototherapy) for atopic dermatitis or currently on topical treatment, but otherwise candidates for systemic treatment.

You may not qualify if…

• Concurrent participation in an interventional clinical trial which modifies patient care.
• The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Where it is running

• Cahaba Dermatology & Skin Health Center- Site Number : 8400046 — Birmingham, Alabama, United States
• C2 Research Center, LLC- Site Number : 8400071 — Montgomery, Alabama, United States
• Phoenix Children's Hospital, Inc.- Site Number : 8400015 — Phoenix, Arizona, United States
• Orange County Research Institute- Site Number : 8400028 — Anaheim, California, United States
• Axis Clinical Trials- Site Number : 8400025 — Los Angeles, California, United States
• Madera Family Medical Group- Site Number : 8400054 — Madera, California, United States
• Carey Chronis, MD, FAAP- Site Number : 8400033 — Ventura, California, United States
• Daxia Trials- Site Number : 8400082 — Boca Raton, Florida, United States
• Frieder Dermatology- Site Number : 8400085 — Boca Raton, Florida, United States
• Pediatric Center of Excellence (PCE) - Miami Pediatric Endocrinology, LLC- Site Number : 8400072 — Coral Gables, Florida, United States
• Green Dermatology and Cosmetic Center. Site Number : 8400078 — Deerfield Beach, Florida, United States
• Amedica Research Institute, Inc.- Site Number : 8400067 — Hialeah, Florida, United States
• Eastern Research, Inc.- Site Number : 8400032 — Hialeah, Florida, United States
• Premier Dermatology Partners- Site Number : 8400075 — Miami, Florida, United States
• Nicklaus Children's Hospital - Miami - Southwest 62nd Avenue- Site Number : 8400074 — Miami, Florida, United States
• Vista Health Research, LLC- Site Number : 8400034 — Miami, Florida, United States
• Pediatric & Adult Research Center- Site Number : 8400040 — Orlando, Florida, United States
• Elias Dermatology LLC- Site Number : 8400086 — Pembroke Pines, Florida, United States
• Elias Dermatology LLC- Site Number : 8400087 — Pembroke Pines, Florida, United States
• Centricity Research Talbotton - DBA IACT Health Research at Talbotton Site Number : 8400056 — Columbus, Georgia, United States
• Northwestern University Feinberg School of Medicine- Site Number : 8400001 — Chicago, Illinois, United States
• NorthShore University HealthSystem - Skokie- Site Number : 8400064 — Skokie, Illinois, United States
• The Indiana Clinical Trial Center - Plainfield - Edwards Drive- Site Number : 8400007 — Plainfield, Indiana, United States
• The Indiana Clinical Trials Center, PC Site Number : 8400007 — Plainfield, Indiana, United States
• C Squared Research Center- Site Number : 8400068 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.